Invesco Ltd. Health Catalyst, Inc. Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 106,368 shares of HCAT stock, worth $319,104. This represents 0.0% of its overall portfolio holdings.

Number of Shares

106,368

Previous 97,599 8.98%

Holding current value

$319,104

Previous $442,000 9.28%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$3.58 - $4.52 $31,393 - $39,635	8,769 Added 8.98%	106,368 $401,000
Q1 2025 May 12, 2025	BUY	$3.97 - $7.42 $70,368 - $131,519	17,725 Added 22.19%	97,599 $442,000
Q4 2024 Feb 13, 2025	BUY	$6.9 - $9.02 $11,198 - $14,639	1,623 Added 2.07%	79,874 $564,000
Q3 2024 Nov 12, 2024	SELL	$5.48 - $8.83 $3,825 - $6,163	-698 Reduced 0.88%	78,251 $636,000
Q2 2024 Aug 13, 2024	SELL	$5.53 - $7.28 $14,731 - $19,393	-2,664 Reduced 3.26%	78,949 $504,000
Q1 2024 May 14, 2024	BUY	$7.44 - $11.21 $111,763 - $168,396	15,022 Added 22.56%	81,613 $614,000
Q4 2023 Feb 12, 2024	SELL	$6.71 - $10.16 $71,568 - $108,366	-10,666 Reduced 13.81%	66,591 $616,000
Q3 2023 Nov 13, 2023	BUY	$9.35 - $14.32 $111,601 - $170,923	11,936 Added 18.27%	77,257 $781,000
Q2 2023 Aug 11, 2023	SELL	$9.86 - $13.12 $525,133 - $698,758	-53,259 Reduced 44.91%	65,321 $816,000
Q1 2023 May 12, 2023	BUY	$10.23 - $14.76 $237,131 - $342,136	23,180 Added 24.3%	118,580 $1.38 Million
Q4 2022 Feb 13, 2023	SELL	$6.86 - $11.32 $19,585 - $32,318	-2,855 Reduced 2.91%	95,400 $1.01 Million
Q3 2022 Nov 14, 2022	SELL	$9.3 - $18.27 $6.94 Million - $13.6 Million	-746,028 Reduced 88.36%	98,255 $953,000
Q2 2022 Aug 15, 2022	BUY	$11.79 - $27.63 $1.18 Million - $2.76 Million	99,855 Added 13.41%	844,283 $12.2 Million
Q1 2022 May 16, 2022	BUY	$20.67 - $40.33 $1.25 Million - $2.45 Million	60,652 Added 8.87%	744,428 $19.5 Million
Q4 2021 Feb 14, 2022	BUY	$36.68 - $54.02 $1.8 Million - $2.65 Million	48,984 Added 7.72%	683,776 $27.1 Million
Q3 2021 Nov 15, 2021	BUY	$49.57 - $58.15 $27.3 Million - $32 Million	549,923 Added 647.97%	634,792 $31.7 Million
Q2 2021 Aug 17, 2021	BUY	$47.17 - $58.64 $2.55 Million - $3.18 Million	54,145 Added 176.23%	84,869 $4.71 Million
Q1 2021 May 17, 2021	BUY	$42.51 - $54.07 $234,995 - $298,898	5,528 Added 21.94%	30,724 $1.44 Million
Q4 2020 Feb 16, 2021	BUY	$31.9 - $44.89 $106,195 - $149,438	3,329 Added 15.22%	25,196 $1.1 Million
Q3 2020 Nov 16, 2020	SELL	$28.55 - $36.91 $117,540 - $151,958	-4,117 Reduced 15.84%	21,867 $800,000
Q2 2020 Aug 14, 2020	BUY	$24.0 - $32.87 $24,432 - $33,461	1,018 Added 4.08%	25,984 $758,000
Q1 2020 May 15, 2020	SELL	$17.8 - $37.6 $6.65 Million - $14 Million	-373,362 Reduced 93.73%	24,966 $653,000
Q4 2019 Feb 14, 2020	BUY	$26.44 - $40.63 $10.5 Million - $16.2 Million	398,328 New	398,328 $13.8 Million

Others Institutions Holding HCAT

# of Institutions

169

Shares Held

54.7M

Call Options Held

452K

Put Options Held

21.8K

View Full List

About Health Catalyst, Inc.

Ticker HCAT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 54,723,400
Market Cap $164M
Description
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...

More about HCAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account